What changed in the March 05, 2026 Jefferies note on HELP analyst rating?

Jefferies reiterated a Buy on HELP on March 05, 2026 and emphasized that additional Phase 2 data is needed for greater Street confidence. No new price target was issued and the note kept a cautious, conditional tone.

Does the Jefferies note include a new HELP price target?

No. Jefferies did not publish a new HELP price target with the March 05, 2026 reiteration, signaling analysts want more clinical evidence before revising valuation guidance.

How should investors interpret the maintained HELP analyst rating?

A maintained Buy shows continued analyst support but not certainty. Investors should weigh trial timelines, potential volatility, and position sizing until follow-up data reduces clinical risk.

What does Meyka AI say about the HELP analyst rating and stock outlook?

Meyka AI rates HELP with a grade of B and highlights that the reiterated Buy is conditional on more data. Our AI view stresses monitoring upcoming readouts and acknowledges limited analyst coverage as a risk.

Analyst Ratings

Jefferies Maintains Buy on HELP (Cybin Inc. Common Stock) Mar 2026

ByHuzaifa Zahoor March 6, 2026

The key development: Jefferies maintained a Buy on Cybin Inc. Common Stock (HELP) on March 05, 2026. The HELP analyst rating was reiterated after new Phase 2 data, with Jefferies noting that additional data is needed before the Street gains greater conviction. Market reaction has followed, with a 6.21% move noted since the call. We review what the Jefferies call means for investors, how it ties to recent price action, and how Meyka AI’s grading frames the outlook for HELP analyst rating.